Outsourced Pharma Services & Pharma Tech Q2 2025

Outsourced Pharma Services & Pharma Tech

Person analyzing chemical experiment by tablet in modern lab

Outsourced Pharma Services & Pharma Tech Sector Brief Header

Harris-Williams Bio-Crop 0074 1198 GeoffSmith

Profile

Harris-Williams Bio-Crop 0106 0433 TylerBradshaw

Harris-Williams Bio-Crop 0040 JulianFeneley 1

Harris-Williams Bio-Crop 0021 089 DanLinsalata

Harris-Williams Bio-Crop 0006 SDoering casual

Harris-Williams Bio-Crop 0003 AndreyDvorkin

bio-crop 0000 0855 RobCrampton

Outsourced Pharma Services & Pharma Tech Sector Brief LI web-media

View our Q2 2025 update on the outsourced pharma services and pharma tech space, including the latest industry trends and news driving M&A.

Outsourced Pharma Services & Pharma Tech | Q2 2025 | M&A Trends

Site Map

Privacy

Terms Of Use

Cookie Policy

Disclosures

We are a global investment bank specializing in M&A and private capital advisory services. Clients worldwide rely on us to help unlock value in their business and turn ambitious goals into reality.

About Us

Our Capabilities

We have eight dedicated Industry Groups led by senior professionals who have deep knowledge and experience across sectors, service offerings, and geographies.

Our Industries

Access our latest insights on evolving industry dynamics and marketplace trends.

Our Insights

Our momentum as a firm is strong. We carry this momentum forward by hiring people who are smart, driven, and principled. If you are a team player who thrives on collaborating with colleagues and clients, we invite you to learn more about our career opportunities. 